ethyl 6-bromo-4-oxo-1,4-dihydroquinoline-3-carboxylate
CAS: 79607-23-1
Ref. 3D-EDA60723
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 25g | Discontinued | ||
| 50g | Discontinued | ||
| 100g | Discontinued |
Product Information
Name:
ethyl 6-bromo-4-oxo-1,4-dihydroquinoline-3-carboxylate
Synonyms:
- Ethyl 6-Bromo-4-Hydroxy-3-Quinolinecarboxylate
- Ethyl 6-Bromo-4-Hydroxyquinoline-3-Carboxylate
- Buttpark 21\09-49
- Ethyl 6-Bromo-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate
- 4-Hydroxy-6-bromoquinoline-3-carboxylicacidethylester
- Ethyl 4-hydroxy-6-bromoquinoline-3-carboxylate
Description:
Ethyl 6-bromo-4-oxo-1,4-dihydroquinoline-3-carboxylate (EBC) is a potent, selective and orally active anti-cancer drug that has been shown to inhibit the proliferation of cancer cells in vitro. EBC is a novel anticancer agent that inhibits the growth of cancer cells by inhibiting protein synthesis. The cytotoxic effect of EBC is mediated by inhibition of protein synthesis through reversible inhibition of ribosomal activity. This compound also inhibits DNA topoisomerase II and DNA gyrase, which are enzymes that maintain the integrity of bacterial DNA. Maximized pharmacokinetic properties have been achieved in animal models using an oral formulation.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
296.12 g/mol
Formula:
C12H10BrNO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
